Shocking New Study Shows Chemo Kills Half of Cancer Patients, Not Cancer Itself
- Shocking New Study Shows Chemo Kills Half of Cancer Patients, Not Cancer Itself
by Amy Goodrich, http://www.naturalnews.com/
(NaturalNews) A new landmark study found that up to 50 percent of people who receive chemotherapy are killed by the treatment, not cancer itself. For the first time, researchers from Public Health England and Cancer Research U.K. examined the numbers of cancer patients who died within 30 days of starting chemotherapy.
Chemotherapy is an invasive and toxic treatment to kill cancer cells. Unfortunately, chemo doesn’t differentiate between a cancerous or a healthy cell. As a result, it kills all living matter on its way. Furthermore, chemo drugs are known to damage the immune system. This makes cancer patients more vulnerable to infections, which may contribute to the high mortality rates.
Chemo kills within the first 30 days
The study, which was published in The Lancet Oncology medical journal, looked at more than 23,000 women with breast cancer and nearly 10,000 men with lung cancer who underwent chemotherapy in 2014. Of those treated with chemotherapy, 1,383 died within 30 days.
As reported by the Telegraph, on average 8.4 percent of lung cancer patients and 2.4 percent of breast cancer patients died within a month. That number, however, depended hugely on the hospital.
The mortality rate at Lancashire Teaching Hospitals for those undergoing palliative chemotherapy for lung cancer, for instance, was 28 percent. But in Milton Keynes the death rate for lung cancer treatment went up to 50.9 percent.
According to Dr. Jem Rashbass, Cancer Lead for Public Health England, chemotherapy is a crucial part of cancer treatment. He, however, admitted that chemotherapy drugs are potent chemical substances with significant side effects.
He further noted that getting the balance right to aggressively treat patients can be hard. Therefore, hospitals with death rates outside the expected range have had the findings shared with them. Also, they have been asked to review their practice and data.
No comments yet.